期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Anti-corisin immunotherapy:therapeutic perspective for reducing the risk of developing COVID-19 coagulopathy?
1
作者 lippi giuseppe 《Infectious Diseases Research》 2024年第3期30-31,共2页
Corisin,a 19 amino acid proapoptotic peptide derived from the lung microbiota(i.e.,by Staphylococci),is implicated in the pathogenesis of acute lung injury and exacerbation of pulmonary fibrosis.Recent evidence also s... Corisin,a 19 amino acid proapoptotic peptide derived from the lung microbiota(i.e.,by Staphylococci),is implicated in the pathogenesis of acute lung injury and exacerbation of pulmonary fibrosis.Recent evidence also suggests that this molecule may have a role in lung thrombosis,as its concentration correlates with a prothrombotic state.It has also been demonstrated that corisin inhibition by using monoclonal antibodies is effective inhibiting pulmonary fibrosis and venous thrombosis in patients with coronavirus disease 2019(COVID-19).Further studies should hence be planned to verify whether anti-corisin immunotherapy could become a reliable therapeutic perspective against the risk of developing COVID-19 coagulopathy. 展开更多
关键词 corisin COVID-19 SARS-CoV-2 IMMUNOTHERAPY
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部